Caroline Jansson

Caroline Jansson

Auto-generated profile, based on publicly available information

Caroline Jansson

Division of Clinical Genetics, Department of Laboratory Medicine, Lund Uni-versity, Lund, Sweden

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
BRBahar Rastegar
Bahar Rastegar
NANatalie Andersson
Natalie Andersson
APAlexandra Petersson
Alexandra Petersson
JKJenny Karlsson
Jenny Karlsson
SCSubhayan Chattopadhyay
Subhayan Chattopadhyay
DGDavid Gisselsson
David Gisselsson
Purpose: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia have an OS of only around 50%. We here identify key events in the pathogenesis of diffuse anaplasia by mapping cancer cell evolution over anatomic space in Wilms tumors. Experimental Design: We spatially mapped subclonal landscapes in a retrospective cohort of 20 Wilms tumors using high-resolution copy-number profiling and TP53 mutation analysis followed by clonal deconvolution and phylogenetic reconstruction. Tumor whole-mount sections (WMS) were utilized to characterize the distribution of subclones across anatomically distinct tumor compartments. Results: Compared with non-diffuse anaplasia Wilms tumors, tumors with diffuse anaplasia showed a significantly higher number of genetically distinct tumor cell subpopulations and more complex phylogenetic trees, including high levels of phylogenetic species richness, divergence, and irregularity. All regions with classical anaplasia showed TP53 alterations. TP53 mutations were frequently followed by saltatory evolution and parallel loss of the remaining wild-type (WT) allele in different regions. Morphologic features of anaplasia increased with copy-number aberration (CNA) burden and regressive features. Compartments demarcated by fibrous septae or necrosis/regression were frequently (73%) associated with the emergence of new clonal CNAs, although clonal sweeps were rare within these compartments. Conclusions: Wilms tumors with diffuse anaplasia display significantly more complex phylogenies compared with non-diffuse anaplasia Wilms tumors, including features of saltatory and parallel evolution. The subclonal landscape of individual tumors was constrained by anatomic compartments, which should be considered when sampling tissue for precision diagnostics.

8 August 2025 in The Journal of Pathology
Verified
Journal Article
Open access
JSJoachim T Siaw
Joachim T Siaw
PMPeter Merseburger
Peter Merseburger
MBMarcus Borenäs
Marcus Borenäs
CJCaroline Jansson
Caroline Jansson
JKJenny Karlsson
Jenny Karlsson
JEJimmy Van den Eynden
Jimmy Van den Eynden
High‐risk neuroblastomas exhibit a high degree of intratumoral heterogeneity. Single‐cell RNA sequencing has greatly improved our understanding of these tumors, but the method lacks cellular tissue context and spatial information about local signaling dynamics. To address this, we profiled untreated and chemotherapy‐treated high‐risk neuroblastomas from archived, formalin‐fixed, paraffin‐embedded (FFPE) tissues from two patients using spatial transcriptomics. We confirmed the transcriptional and cellular heterogeneous nature of the neuroblastoma microenvironment and identified several unique spatial niches and patterns. In one of the treated tumors, a spatially constrained cluster of undifferentiated and 11p‐gained cancer cells was identified, surrounded by a rim of macrophages. A signaling interaction between the chemokine CCL18 and its receptor PITPNM3 was predicted between these cells. In the other tumor, we identified a stromal cluster with high transcriptional similarity to the adrenal cortex. These adrenocortical‐like cells expressed several oncogenic ligand‐encoding genes (e.g. ALKAL2 and NRTN), which were predicted to communicate with neighboring cancer cells that expressed the corresponding receptors (e.g. ALK, RET). Several of these interactions were further validated experimentally and were shown to be clinically relevant. Collectively, our spatial analysis identifies multiple previously unrecognized signaling axes that may offer novel therapeutic options in neuroblastoma. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

22 December 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJoachim T. Siaw
Joachim T. Siaw
PMPeter Merseburger
Peter Merseburger
MBMarcus Borenäs
Marcus Borenäs
CJCaroline Jansson
Caroline Jansson
JKJenny Karlson
Jenny Karlson
JEJimmy Van den Eynden
Jimmy Van den Eynden
High-risk neuroblastomas exhibit a high degree of intratumoral heterogeneity. Single-cell RNA sequencing has greatly improved our understanding of these tumors, but the method lacks cellular tissue context and spatial information about local signaling dynamics. To address this gap, we profiled untreated and chemotherapy-treated high-risk neuroblastomas from 2 patients using spatial transcriptomics. We confirmed the transcriptional and cellular heterogeneous nature of the neuroblastoma microenvironment and identified several unique spatial niches and patterns. In one of the treated tumors, a spatially constrained cluster of undifferentiated and 11p-gained cancer cells was identified, surrounded by a rim of macrophages. A signaling interaction between the chemokine CCL18 and its receptor PITPNM3 was predicted between these cells and we experimentally demonstrated that CCL18 increases neuroblastoma cell migration. In the other tumor, we identified a stromal cluster with high transcriptional similarity to the adrenal cortex. These adrenocortical-like cells expressed the ALK ligand ALKAL2 and were predicted to communicate with neighboring ALK expressing cancer cells. We demonstrated a unique developmental pattern of adrenal medulla-specific expression of ALK and adrenocortical-specific expression of ALKAL2 , suggesting a role of these signaling interactions in neuroblastoma carcinogenesis.

25 November 2025
Verified
Other
Open access
BRBahar Rastegar
Bahar Rastegar
NANatalie Andersson
Natalie Andersson
APAlexandra Petersson
Alexandra Petersson
JKJenny Karlsson
Jenny Karlsson
SCSubhayan Chattopadhyay
Subhayan Chattopadhyay
DGDavid Gisselsson
David Gisselsson
Supplementary Table 2. Representativeness of study participants. Details on how the patients with Wilms tumor in the present study compare to the general population of patients diagnosed with with Wilms tumor.

25 November 2025
Verified
Other
Open access
BRBahar Rastegar
Bahar Rastegar
NANatalie Andersson
Natalie Andersson
APAlexandra Petersson
Alexandra Petersson
JKJenny Karlsson
Jenny Karlsson
SCSubhayan Chattopadhyay
Subhayan Chattopadhyay
DGDavid Gisselsson
David Gisselsson
Supplementary Figure 1 Geographic overview of histological and genetic features.

16 September 2024
Verified
Other
Open access
BRBahar Rastegar
Bahar Rastegar
NANatalie Andersson
Natalie Andersson
APAlexandra Petersson
Alexandra Petersson
JKJenny Karlsson
Jenny Karlsson
SCSubhayan Chattopadhyay
Subhayan Chattopadhyay
DGDavid Gisselsson
David Gisselsson
Purpose: While patients with intermediate-risk Wilms tumors (WT) now have an overall survival rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia (DA) have an overall survival of only around 50%. We here identify key events in the pathogenesis of DA by mapping cancer cell evolution over anatomic space in WTs. Experimental Design: We spatially mapped subclonal landscapes in a retrospective cohort of 20 WTs using high-resolution copy number profiling and TP53 mutation analysis followed by clonal deconvolution and phylogenetic reconstruction. Tumor whole mount sections were utilized to characterize the distribution of subclones across anatomically distinct tumor compartments. Results: Compared to non-DA WTs, tumors with DA showed a significantly higher number of genetically distinct tumor cell subpopulations and more complex phylogenetic trees, including high levels of phylogenetic species richness, divergence and irregularity. All regions with classical anaplasia showed TP53 alterations. TP53 mutations were frequently followed by saltatory evolution and parallel loss of the remaining wild-type allele in different regions. Morphological features of anaplasia increased with copy number aberration (CNA) burden and regressive features. Compartments demarcated by fibrous septae or necrosis/regression were frequently (73%) associated with the emergence of new clonal CNAs, while clonal sweeps were rare within these compartments. Conclusions: WTs with DA display significantly more complex phylogenies compared to non-DA WTs, including features of saltatory and parallel evolution. The subclonal landscape of individual tumors was constrained by anatomic compartments, which should be considered when sampling tissue for precision diagnostics.